<DOC>
	<DOCNO>NCT02773381</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate effect oral semaglutide compare placebo postprandial glucose triglyceride metabolism , energy intake , appetite sensation gastric empty subject Type 2 diabetes</brief_summary>
	<brief_title>A Trial Investigating Effect Oral Semaglutide Compared With Placebo Postprandial Glucose Triglyceride Metabolism , Energy Intake , Appetite Sensations Gastric Emptying Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female , age 1875 year ( inclusive ) time sign informed consent Subjects diagnose type 2 diabetes mellitus least 90 day prior day screen . Treated diet exercise and/or metformin monotherapy . The metformin dose unchanged period 30 day prior screen Body mass index ( BMI ) 20.038 kg/m^2 ( inclusive ) HbA1c ( glycosylated haemoglobin ) 6.09.0 % ( inclusive ) Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) Family personal history Multiple Endocrine Neoplasia Type 2 Medullary Thyroids Carcinoma History pancreatitis ( acute chronic ) Presence clinically significant symptom gastrointestinal disorder potentially affect absorption drug and/or nutrient , judge investigator History major surgical procedure involve stomach potentially affect absorption trial product ( e.g . subtotal total gastrectomy , sleeve gastrectomy , gastric bypass surgery ) History presence clinically relevant respiratory , metabolic ( include dyslipedimia , however mild dyslipidaemia , define screen total cholesterol equal 7.8 mmol/L screen triglyceride equal 3.42 mmol/L accept ) , renal , hepatic , gastrointestinal , endocrinological condition ( except condition associate diabetes mellitus ) History presence malignant neoplasm within last 5 year ( except basal squamous cell skin cancer insitu carcinoma ) History presence cardiovascular disease include stable unstable angina , myocardial infarction , transient ischaemic attack , stroke , cardiac decompensation , clinically significant arrhythmias conduction disorder Renal impairment estimate Glomerular Filtration Rate ( eGFR ) 60 mL /min define CKDEPI use IDMS serum creatinine measurement day screen Impaired liver function , define ALT equal 2.5 time upper normal limit ( UNL ) day screen Smoker ( define subject smoke 1 cigarette equivalent per day ) . During inpatient period , subject must willing completely refrain smoke use nicotine substitute product Known suspected alcohol abuse within 1 year screening ( defined regular intake 21 unit weekly men 14 unit weekly woman one unit alcohol equal 300 mL beer lager , one glass ( 100 mL ) wine , 25 mL spirit )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>